Actively Recruiting
Randomized Study Comparing Wide Local Excision Alone Versus with Sentinel Lymph Node Biopsy in Older Adults With Early-Stage Melanoma
Led by ECOG-ACRIN Cancer Research Group · Updated on 2026-09-24
428
Participants Needed
181
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the treatment of older adults aged 75 and above with early-stage cutaneous melanoma. The study compares the effectiveness of wide local excision WLE alone to the usual care of WLE combined with sentinel lymph node SLN biopsy. The main goal is to see if the less invasive WLE alone can provide similar results in preventing melanoma recurrence. This phase III trial also aims to assess patient-reported outcomes and the impact of geriatric assessments on treatment results. Participants are randomly assigned to one of two groups one group receives WLE plus SLN biopsy, and the other group receives WLE alone. Both groups may undergo surveillance of the lymph node area and receive additional treatments called adjuvant therapies if needed. Throughout the study, participants may have imaging tests such as computed tomography CT, positron emission tomography PETCT, or ultrasound. After initial treatment, patients are monitored closely with regular follow-ups. During the study, participants will be followed every four months for two years and then every six months up to five years after randomization. Researchers will collect data on recurrence-free survival, overall survival, melanoma-specific survival, safety, and patient quality of life. The study also involves comprehensive geriatric assessments and questionnaires to evaluate physical and functional status. These measures will help develop tools to predict risks and guide future surgical decisions for older adults with melanoma.
CONDITIONS
Brief Title
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here